{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Kansas City",
      "state": "MO",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "79210",
      "recalling_firm": "Nostrum Laboratories Inc",
      "address_1": "1800 N Topping Ave",
      "address_2": "N/A",
      "postal_code": "64120-1228",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0473-2018",
      "product_description": "Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only.  Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02",
      "product_quantity": "1,439,000 oral capsules",
      "reason_for_recall": "Presence of Foreign Tablets/Capsules",
      "recall_initiation_date": "20180213",
      "center_classification_date": "20180220",
      "termination_date": "20181213",
      "report_date": "20180228",
      "code_info": "Lot: CAL173502; Exp. 09/19"
    }
  ]
}